Response to Comment on: Straznicky et al. Neuroadrenergic Dysfunction Along the Diabetes Continuum: A Comparative Study in Obese Metabolic Syndrome Subjects. Diabetes 2012;61:2506–2516

Benzer Materyaller

• Comment on: Straznicky et al. Neuroadrenergic Dysfunction Along the Diabetes Continuum: A Comparative Study in Obese Metabolic Syndrome Subjects. Diabetes 2012;61:2506–2516
  Yazar:: Frontoni, Simona
  Baskı/Yayın Bilgisi: (2013)
• Neuroadrenergic Dysfunction Along the Diabetes Continuum: A Comparative Study in Obese Metabolic Syndrome Subjects
  Yazar:: Straznicky, Nora E., ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Comment on: Marquez et al. Low-Frequency Variants in HMGA1 Are Not Associated With Type 2 Diabetes Risk. Diabetes 2012;61:524–530
  Yazar:: Brunetti, Antonio, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Response to Comment on: Marquez et al. Low-Frequency Variants in HMGA1 Are Not Associated With Type 2 Diabetes Risk. Diabetes 2012;61:524–530
  Yazar:: Froguel, Philippe, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Comment on: Visinoni et al. The Role of Liver Fructose-1,6-Bisphosphatase in Regulating Appetite and Adiposity. Diabetes 2012;61:1122–1132
  Yazar:: Masotti, Andrea
  Baskı/Yayın Bilgisi: (2012)